{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T04:46:33Z","timestamp":1791693993520,"version":"4.3.4"},"reference-count":34,"publisher":"Walter de Gruyter GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jpem-2026-0244_abs_001\">\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To evaluate stature in patients with celiac disease (CD) adherent to a gluten-free diet (GFD), determine the prevalence of growth hormone deficiency (GHD), and assess the associations between stature and serum insulin-like growth factor-1 (IGF-1), insulin-like growth factor\u2013binding protein 3 (IGFBP-3), and FGF 21 levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0244_abs_002\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>In this prospective cross-sectional study, 141 pediatric patients with CD (79 females) who had adhered to a GFD for at least 2\u00a0years were included. Anthropometric and clinical data were obtained from medical records. Serum IGF-1, IGFBP-3, and FGF21 levels were measured in fasting samples. Growth hormone stimulation tests (L-dopa and clonidine) were performed in patients with a height &gt;1.5 SDS below target height\u00a0(TH).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0244_abs_003\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Twelve patients (8.5\u202f%) had persistent short stature despite long-term adherence to a GFD. Growth hormone deficiency was diagnosed in three patients (2.1\u202f% of the entire cohort; 25\u202f% of patients with persistent short stature). Patients with persistent short stature without GHD had significantly lower serum IGF-1 and IGFBP-3 standard deviation scores than those with normal stature, whereas serum FGF21 concentrations did not differ significantly between the groups. Serum FGF21 concentrations were not significantly correlated with height SDS, IGF-1, IGFBP-3, or other anthropometric variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jpem-2026-0244_abs_004\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Persistent short stature may occur despite long-term adherence to a GFD in a small proportion of children and adolescents with CD. GHD was identified in 2.1\u202f% of patients, emphasizing the importance of growth monitoring. Lower IGF-1 and IGFBP-3 SDS in patients with persistent short stature without GHD suggest alterations within the GH\u2013IGF axis. Serum FGF21 concentrations were not associated with stature, suggesting that persistent growth impairment in treated CD is likely multifactorial and is not explained by circulating FGF21\u00a0alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1515\/jpem-2026-0244","type":"journal-article","created":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:55:57Z","timestamp":1791690957000},"source":"Crossref","is-referenced-by-count":0,"title":["Serum FGF-21 levels and stature in children and adolescents with celiac disease on a gluten-free diet"],"prefix":"10.1515","author":[{"given":"F\u0131rat","family":"Kaya","sequence":"first","affiliation":[{"name":"Department of Pediatrics , University of Health Sciences, \u015ei\u015fli Hamidiye Etfal Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nafiye","family":"Urganc\u0131","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology , University of Health Sciences, \u015ei\u015fli Hamidiye Etfal Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmet","family":"U\u00e7ar","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology , University of Health Sciences, \u015ei\u015fli Hamidiye Etfal Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zge Pelin","family":"Akbay","sequence":"additional","affiliation":[{"name":"Department of Pediatric Endocrinology , University of Health Sciences, \u015ei\u015fli Hamidiye Etfal Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ay\u015fe Merve","family":"Usta","sequence":"additional","affiliation":[{"name":"Department of Pediatric Gastroenterology , University of Health Sciences, \u015ei\u015fli Hamidiye Etfal Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedanur","family":"Celik","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , University of Health Sciences, \u015ei\u015fli Hamidiye Etfal Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5468-9304","authenticated-orcid":false,"given":"Mustafa Safa","family":"Kas\u0131m","sequence":"additional","affiliation":[{"name":"Department of Pediatrics , University of Health Sciences, \u015ei\u015fli Hamidiye Etfal Training and Research Hospital , Istanbul , T\u00fcrkiye"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2026,10,12]]},"reference":[{"key":"2026101103555319189_j_jpem-2026-0244_ref_001","doi-asserted-by":"crossref","unstructured":"Giovenale, D, Meazza, C, Cardinale, GM, Sposito, M, Mastrangelo, C, Messini, B, et al.. The prevalence of growth hormone deficiency and celiac disease in short children. Clin Med Res 2006;4:180\u20133. https:\/\/doi.org\/10.3121\/cmr.4.3.180.","DOI":"10.3121\/cmr.4.3.180"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_002","unstructured":"Ghiselli, A, Bizzarri, B, Gaiani, F, Semeraro, F, Iuliano, S, Di Mario, F, et al.. Growth changes after gluten-free diet in pediatric celiac patients: a literature review. Acta Biomed 2018;89:5\u201310. https:\/\/doi.org\/10.23750\/abm.v89i9-S.7871."},{"key":"2026101103555319189_j_jpem-2026-0244_ref_003","doi-asserted-by":"crossref","unstructured":"Bozzola, M, Meazza, C, Villani, A. Auxo-endocrinological approach to celiac children. Diseases 2015;3:111\u201321. https:\/\/doi.org\/10.3390\/diseases3020111.","DOI":"10.3390\/diseases3020111"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_004","doi-asserted-by":"crossref","unstructured":"Giovenale, D, Meazza, C, Cardinale, GM, Farinelli, E, Mastrangelo, C, Messini, B, et al.. Growth hormone treatment in prepubertal children with celiac disease and growth hormone deficiency. J\u00a0Pediatr Endocrinol Metab 2007;20:465\u201371.","DOI":"10.1097\/MPG.0b013e3180de5e0a"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_005","doi-asserted-by":"crossref","unstructured":"Chen, W, Hoo, RLC, Konishi, M, Itoh, N, Lee, PC, Ye, HY, et al.. Growth hormone induces hepatic production of fibroblast growth factor 21. J\u00a0Biol Chem 2011;286:34559\u201366.","DOI":"10.1074\/jbc.M111.285965"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_006","doi-asserted-by":"crossref","unstructured":"Inagaki, T, Lin, VY, Goetz, R, Mohammadi, M, Mangelsdorf, DJ, Kliewer, SA, et al.. Inhibition of growth hormone signaling by fasting-induced FGF21. Cell Metab 2008;8:77\u201383. https:\/\/doi.org\/10.1016\/j.cmet.2008.05.006.","DOI":"10.1016\/j.cmet.2008.05.006"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_007","doi-asserted-by":"crossref","unstructured":"Lee, YJ, Jung, SY, Lee, YA, Kim, J, Lee, SY, Shin, CH, et al.. Serum FGF21 and growth in children of short stature. J\u00a0Korean Med Sci 2023;38:e52.","DOI":"10.3346\/jkms.2023.38.e63"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_008","doi-asserted-by":"crossref","unstructured":"Keuper, M, H\u00e4ring, HU, Staiger, H. Circulating FGF21 in human health and metabolic disease. Exp Clin Endocrinol Diabetes 2020;128:752\u201370. https:\/\/doi.org\/10.1055\/a-0879-2968.","DOI":"10.1055\/a-0879-2968"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_009","doi-asserted-by":"crossref","unstructured":"Fazeli, PK, Misra, M, Goldstein, M, Miller, KK, Klibanski, A. Fibroblast growth factor-21 May mediate growth hormone resistance in anorexia nervosa. J\u00a0Clin Endocrinol Metab 2010;95:369\u201374. https:\/\/doi.org\/10.1210\/jc.2009-1730.","DOI":"10.1210\/jc.2009-1730"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_010","doi-asserted-by":"crossref","unstructured":"Kubicky, RA, Wu, S, Kharitonenkov, A, De Luca, F. Role of fibroblast growth factor 21 in undernutrition-related attenuation of growth in mice. Endocrinology 2012;153:2287\u201395. https:\/\/doi.org\/10.1210\/en.2011-1909.","DOI":"10.1210\/en.2011-1909"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_011","doi-asserted-by":"crossref","unstructured":"Hermanussen, M, Cole, TJ. The calculation of target height reconsidered. Horm Res 2003;59:180\u20133. https:\/\/doi.org\/10.1159\/000069321.","DOI":"10.1159\/000069321"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_012","unstructured":"Centers for Disease Control and Prevention. CDC growth charts. Available from: https:\/\/www.cdc.gov\/growthcharts."},{"key":"2026101103555319189_j_jpem-2026-0244_ref_013","doi-asserted-by":"crossref","unstructured":"Reinehr, T, Tittel, SR, Holle, R, Wiegand, S, Gellhaus, I, Hebebrand, J, et al.. Comparison of cardiovascular risk factors between children and adolescents with classes III and IV obesity. Int J Obes 2021;45:1061\u201373. https:\/\/doi.org\/10.1038\/s41366-021-00773-x.","DOI":"10.1038\/s41366-021-00773-x"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_014","doi-asserted-by":"crossref","unstructured":"Tanner, JM, Whitehouse, RH. Clinical longitudinal standards for height, weight, height velocity, and stages of puberty. Arch Dis Child 1976;51:170\u20139. https:\/\/doi.org\/10.1136\/adc.51.3.170.","DOI":"10.1136\/adc.51.3.170"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_015","doi-asserted-by":"crossref","unstructured":"Greulich, WW, Pyle, SI. Radiographic atlas of skeletal development of the hand and wrist. Stanford: Stanford University Press; 1959.","DOI":"10.1097\/00000441-195909000-00030"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_016","doi-asserted-by":"crossref","unstructured":"Grimberg, A, DiVall, SA, Polychronakos, C, Allen, DB, Cohen, LE, Quintos, JB, et al.. Guidelines for growth hormone and insulin-like growth factor-I treatment in children and adolescents. Horm Res Paediatr 2016;86:361\u201397. https:\/\/doi.org\/10.1159\/000452150.","DOI":"10.1159\/000452150"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_017","doi-asserted-by":"crossref","unstructured":"Walia, R, Singh, A, Aggarwal, A, Thapa, B, Guptasarma, ML, Bhansali, A, et al.. Look beyond gluten in short stature with celiac disease. Indian J Pediatr 2021;88:550\u20134. https:\/\/doi.org\/10.1007\/s12098-020-03543-1.","DOI":"10.1007\/s12098-020-03543-1"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_018","doi-asserted-by":"crossref","unstructured":"Salardi, S, Cacciari, E, Volta, U, Santoni, R, Ragni, L, Elleri, D, et al.. Growth and adult height in atypical coeliac patients, with or without growth hormone deficiency. J\u00a0Pediatr Endocrinol Metab 2005;18:769\u201375. https:\/\/doi.org\/10.1515\/jpem.2005.18.8.769.","DOI":"10.1515\/JPEM.2005.18.8.769"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_019","doi-asserted-by":"crossref","unstructured":"Joshi, K, Bolia, R. Growth hormone deficiency and celiac disease: the long and short of it. Indian J Pediatr 2021;88:536\u20137. https:\/\/doi.org\/10.1007\/s12098-021-03760-2.","DOI":"10.1007\/s12098-021-03760-2"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_020","unstructured":"Bozzola, M, Montalbano, C, Bozzola, E, Lazzaro, N, Stamati, FA, Ferrara, P, et al.. Growth hormone deficiency and related endocrine disorders in children with celiac disease. SL Gastroenterol 2018;1:116."},{"key":"2026101103555319189_j_jpem-2026-0244_ref_021","doi-asserted-by":"crossref","unstructured":"Nardecchia, S, Auricchio, R, Discepolo, V, Troncone, R. Extra-intestinal manifestations of coeliac disease in children. Front Pediatr 2019;7:56.","DOI":"10.3389\/fped.2019.00056"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_022","doi-asserted-by":"crossref","unstructured":"Iughetti, L, De Bellis, A, Predieri, B, Bizzarro, A, De Simone, M, Balli, F, et al.. Growth hormone impaired secretion and antipituitary antibodies in patients with coeliac disease and poor catch-up growth. Eur J Pediatr 2006;165:897\u2013903. https:\/\/doi.org\/10.1007\/s00431-006-0182-4.","DOI":"10.1007\/s00431-006-0182-4"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_023","doi-asserted-by":"crossref","unstructured":"Delvecchio, M, De Bellis, A, Francavilla, R, Rutigliano, V, Predieri, B, Indrio, F, et al.. Anti-pituitary antibodies in children with newly diagnosed celiac disease. Am J Gastroenterol 2010;105:691\u20136.","DOI":"10.1038\/ajg.2009.642"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_024","doi-asserted-by":"crossref","unstructured":"Aguado, R, Fern\u00e1ndez, S, Est\u00e9vez, OA, Santamar\u00eda, M, Ortega, C. Antiadenohypophysis autoantibodies in patients with nongluten-related gastroenteropathies. J\u00a0Clin Lab Anal 2026;28:59\u201362. https:\/\/doi.org\/10.1002\/jcla.21644.","DOI":"10.1002\/jcla.21644"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_025","doi-asserted-by":"crossref","unstructured":"Bellastella, G, Maiorino, MI, Cirillo, P, Longo, M, Pernice, V, Costantino, A, et al.. Remission of pituitary autoimmunity induced by gluten-free diet in patients with celiac disease. J\u00a0Clin Endocrinol Metab 2020;105:2252\u201361. https:\/\/doi.org\/10.1210\/clinem\/dgz228.","DOI":"10.1210\/clinem\/dgz228"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_026","unstructured":"Zeng, K, Tian, L, Patel, R, Shao, W, Song, Z, Liu, L, et al.. Diet polyphenol curcumin stimulates hepatic FGF21 production. Endocrinology 2017;158:277\u201392."},{"key":"2026101103555319189_j_jpem-2026-0244_ref_027","doi-asserted-by":"crossref","unstructured":"Kaufman, A, Abuqayyas, L, Denney, WS, Tillman, EJ, Rolph, T. AKR-001, an Fc-FGF21 analog, showed sustained pharmacodynamic effects. Cell Rep Med 2020;1:100057.","DOI":"10.1016\/j.xcrm.2020.100057"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_028","doi-asserted-by":"crossref","unstructured":"Gamrot, Z, Adamczyk, P, \u015awi\u0119tochowska, E, Roszkowska-Bjanid, D, Gamrot, J, Szczepa\u0144ska, M, et al.. Fibroblast growth factor 21 in children and adolescents with chronic kidney disease. Physiol Res 2020;69:451\u201360. https:\/\/doi.org\/10.33549\/physiolres.934307.","DOI":"10.33549\/physiolres.934307"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_029","doi-asserted-by":"crossref","unstructured":"Sassano, G, La Bella, S, Di Ludovico, A, Breda, L, Chiarelli, F. GH therapy in children with juvenile idiopathic arthritis. Clin Pediatr Endocrinol 2024;33:1\u201311. https:\/\/doi.org\/10.1297\/cpe.2023-0036.","DOI":"10.1297\/cpe.2023-0036"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_030","doi-asserted-by":"crossref","unstructured":"Mistry, JN, Silvennoinen, S, Zaman, F, S\u00e4vendahl, L, Mariniello, K, Hall, C, et al.. Crosstalk between FGF21 and GH leads to weakened GH receptor signaling and IGF1 expression and is associated with growth failure in very preterm infants. Front Endocrinol (Lausanne) 2023;14:1105602. https:\/\/doi.org\/10.3389\/fendo.2023.1105602.","DOI":"10.3389\/fendo.2023.1105602"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_031","doi-asserted-by":"crossref","unstructured":"Barat, P, Brossaud, J, Bereron, A, Corcuff, JB, Moisan, MP, Lacoste, A, et al.. Abstracts of the 55th annual meeting of the European Society for paediatric endocrinology, Paris. Horm Res Paediatr 2016;86(Suppl 1):1\u2013566.","DOI":"10.1159\/000449142"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_032","doi-asserted-by":"crossref","unstructured":"Wu, S, Levenson, A, Kharitonenkov, A, De Luca, F. Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate. J Biol Chem 2012;287:26060\u20137. https:\/\/doi.org\/10.1074\/jbc.M112.343707.","DOI":"10.1074\/jbc.M112.343707"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_033","doi-asserted-by":"crossref","unstructured":"Grunwald, T, De Luca, F. Role of fibroblast growth factor 21 in\u00a0the\u00a0regulation of statural growth. Curr Pediatr Rev 2015;11:98\u2013105. https:\/\/doi.org\/10.2174\/1573396311666150702105152.","DOI":"10.2174\/1573396311666150702105152"},{"key":"2026101103555319189_j_jpem-2026-0244_ref_034","doi-asserted-by":"crossref","unstructured":"Guasti, L, Silvennoinen, S, Bulstrode, NW, Ferretti, P, Sankilampi, U, Dunkel, L, et al.. Elevated FGF21 leads to attenuated postnatal linear growth through GH resistance in chondrocytes. J\u00a0Clin Endocrinol Metab 2014;99:E2198\u2013206. https:\/\/doi.org\/10.1210\/jc.2014-1566.","DOI":"10.1210\/jc.2014-1566"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0244\/xml","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0244\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T03:56:01Z","timestamp":1791690961000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyterbrill.com\/document\/doi\/10.1515\/jpem-2026-0244\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,12]]},"references-count":34,"alternative-id":["10.1515\/jpem-2026-0244"],"URL":"https:\/\/doi.org\/10.1515\/jpem-2026-0244","relation":{},"ISSN":["0334-018X","2191-0251"],"issn-type":[{"value":"0334-018X","type":"print"},{"value":"2191-0251","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,12]]}}}